These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease. Zhang X; Tellew JE; Luo Z; Moorjani M; Lin E; Lanier MC; Chen Y; Williams JP; Saunders J; Lechner SM; Markison S; Joswig T; Petroski R; Piercey J; Kargo W; Malany S; Santos M; Gross RS; Wen J; Jalali K; O'Brien Z; Stotz CE; Crespo MI; Díaz JL; Slee DH J Med Chem; 2008 Nov; 51(22):7099-110. PubMed ID: 18947224 [TBL] [Abstract][Full Text] [Related]
9. Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles. Vu CB; Pan D; Peng B; Sha L; Kumaravel G; Jin X; Phadke D; Engber T; Huang C; Reilly J; Tam S; Petter RC Bioorg Med Chem Lett; 2004 Oct; 14(19):4831-4. PubMed ID: 15341933 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists. Yao G; Haque S; Sha L; Kumaravel G; Wang J; Engber TM; Whalley ET; Conlon PR; Chang H; Kiesman WF; Petter RC Bioorg Med Chem Lett; 2005 Feb; 15(3):511-5. PubMed ID: 15664803 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists. Dowling JE; Vessels JT; Haque S; Chang HX; van Vloten K; Kumaravel G; Engber T; Jin X; Phadke D; Wang J; Ayyub E; Petter RC Bioorg Med Chem Lett; 2005 Nov; 15(21):4809-13. PubMed ID: 16153830 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists. Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033 [TBL] [Abstract][Full Text] [Related]
13. Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists. Vu CB; Shields P; Peng B; Kumaravel G; Jin X; Phadke D; Wang J; Engber T; Ayyub E; Petter RC Bioorg Med Chem Lett; 2004 Oct; 14(19):4835-8. PubMed ID: 15341934 [TBL] [Abstract][Full Text] [Related]
14. 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2. Matasi JJ; Caldwell JP; Zhang H; Fawzi A; Higgins GA; Cohen-Williams ME; Varty GB; Tulshian DB Bioorg Med Chem Lett; 2005 Aug; 15(16):3675-8. PubMed ID: 15982882 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists. Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554 [TBL] [Abstract][Full Text] [Related]
16. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists. Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354 [TBL] [Abstract][Full Text] [Related]
18. In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease. Shook BC; Rassnick S; Osborne MC; Davis S; Westover L; Boulet J; Hall D; Rupert KC; Heintzelman GR; Hansen K; Chakravarty D; Bullington JL; Russell R; Branum S; Wells KM; Damon S; Youells S; Li X; Beauchamp DA; Palmer D; Reyes M; Demarest K; Tang Y; Rhodes K; Jackson PF J Med Chem; 2010 Nov; 53(22):8104-15. PubMed ID: 20973483 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy. Slee DH; Zhang X; Moorjani M; Lin E; Lanier MC; Chen Y; Rueter JK; Lechner SM; Markison S; Malany S; Joswig T; Santos M; Gross RS; Williams JP; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Wen J; O'Brien Z; Saunders J J Med Chem; 2008 Feb; 51(3):400-6. PubMed ID: 18189346 [TBL] [Abstract][Full Text] [Related]
20. Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamides. Gillespie RJ; Bamford SJ; Clay A; Gaur S; Haymes T; Jackson PS; Jordan AM; Klenke B; Leonardi S; Liu J; Mansell HL; Ng S; Saadi M; Simmonite H; Stratton GC; Todd RS; Williamson DS; Yule IA Bioorg Med Chem; 2009 Sep; 17(18):6590-605. PubMed ID: 19695884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]